WillowWood Global Makes Strategic Investment in Reboocon Bionics, Deepening Commitment to Powered Prosthetic Technology

PR Newswire

Investment strengthens a strategic partnership built around the Intuy® Knee and accelerates access to powered lower limb solutions

MOUNT STERLING, Ohio, Nov. 18, 2026 /PRNewswire/ — WillowWood Global LLC (“WillowWood”), a designer and manufacturer of lower limb prosthetic products, today announced that it has made a strategic investment in Reboocon Bionics B.V. (“Reboocon”), the Netherlands-based developer of the Intuy® Knee, a motorized prosthetic knee. [Financial terms of the transaction were not disclosed.]

WillowWood Logo

The investment builds on the strategic alliance that the two companies formed in 2023 to bring the Intuy Knee to the United States market. Through this deeper relationship, WillowWood and Reboocon intend to advance clinical research, expand access for prosthetic practitioners and their patients, and accelerate the development of next-generation powered lower limb technology.

“Powered technology represents one of the most meaningful opportunities to improve mobility for individuals with above-knee amputations,” said Daniel Rubin, Co-Chief Executive Officer of WillowWood. “Since introducing the Intuy Knee to the United States market, we have seen strong adoption among prosthetic practitioners and their patients, which has validated both the technology and the strength of our partnership. This investment reflects our confidence in Reboocon’s team and our shared commitment to delivering proven, clinically validated solutions to the patients our customers serve.”

“WillowWood has been an exceptional partner, and this investment marks an important milestone for Reboocon,” said Shiqian Wang, Founder and Chief Executive Officer of Reboocon Bionics. “Our goal has always been to help people with mobility challenges regain capability and confidence. With WillowWood’s support, clinical expertise, and strong commercial presence in the United States, we are well positioned to bring the benefits of powered prosthetics to many more people.”

“Following our investment in WillowWood in June 2026, we are delighted to now support the investment in Reboocon to help broaden the combined product portfolio and offer more solutions to more patients worldwide,” said Marta Kowalska, Director at CVC Capital Partners.

“It is well over a decade now since I had the privilege of leading the effort that secured a dedicated reimbursement pathway for powered prosthetic knees in the United States,” said Mahesh Mansukhani, Co-Chief Executive Officer of WillowWood. “That milestone opened the door for patients, but the technology of that era was only a first step. The Intuy Knee reflects everything our field has learned since then, and it is the powered knee I always hoped our industry would one day deliver. Together with Reboocon, we intend to ensure that every patient who can benefit from this technology has the opportunity to access it.”

About WillowWood Global LLC
Founded in 1907 and headquartered in Mt. Sterling, Ohio, WillowWood Global is a designer and manufacturer of lower limb prosthetic products, including liners, feet, vacuum systems, and components. WillowWood serves prosthetic offices and a worldwide network of distributors, and it is guided by its mission to level the playing field. For more information, visit www.willowwood.com.

About Reboocon Bionics B.V.
Founded by Shiqian Wang, Reboocon Bionics develops wearable robotic technologies for individuals with mobility impairments. The company’s flagship product, the Intuy® Knee, is a motorized prosthetic knee designed to restore powered movement for individuals with amputations at or above the knee. For more information, visit www.rbionics.com.

About CVC
CVC is a leading global private markets manager with a network of 29 office locations throughout EMEA, the Americas, and Asia, with approximately €209 billion of assets under management. CVC has seven complementary strategies across private equity, secondaries, credit and infrastructure, for which CVC funds have secured commitments of over €257 billion from some of the world’s leading pension funds and other institutional investors. Funds managed or advised by CVC’s private equity strategy are invested in approximately 150+ companies worldwide, which have combined annual sales of over €240 billion and employ over 660,000 people. For further information about CVC, please visit www.cvc.com.

Media Contact:
Hugo Rubin
Director of Marketing
WillowWood Global LLC
hugo.rubin@willowwood.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/willowwood-global-makes-strategic-investment-in-reboocon-bionics-deepening-commitment-to-powered-prosthetic-technology-302942848.html

SOURCE WillowWood Global LLC

About The Author